Clinical Trials

Focused Clinical Trials

Pure Green Pharmaceuticals engages in research and conducts clinical trials using a two-pronged approach. 

First, our IRB-approved phase II pilot trials provide data for submission to regulatory authorities such as the U.S. Food and Drug Administration (FDA). Trials currently underway include: 

  • Pharmacokinetics trials
  • Diabetic neuropathic pain
  • Menstrual related pain
  • Osteoarthritis knee pain

Second, double-blind randomized phase 2 pivotal trials of our sublingual tablet formulations will be enrolled to demonstrate the safety and efficacy of our products after FDA approves an IND.